What's New
-
new
Position Paper "Japanese Patient-Reported Outcome (PRO) Compendium - The Actual State of Phase III Clinical Trials" is now available.
-
new
Position Paper "Comparison of Drug Discovery Originators and Drug Discovery Support Environments Across Metropolitan Areas" is now available.
-
new
Position Paper "Conditions for Social Acceptance of the Utilization of Health and Medical Information - From an Attitude Survey of the Public and Doctors" is now available.
Pick Up
OPIR Views and Actions No.77 has been added.
OPIR Views and Actions Summary of No.77 is here.
This issue includes the following
-
Pediatric Atopic Dermatitis Testing and Prescription Drugs in NDB Open Data
The Office of Pharmaceutical Industry Research Senior Researcher Shinji Tsubakihara
-
Approval Status of Drugs for Unmet Medical Needs
The Office of Pharmaceutical Industry Research Senior Researcher Natsuko Watanabe
The Office of Pharmaceutical Industry Research Senior Researcher Shinji Tsubakihara -
Nationalities of the top drug generators by global sales
-Trends in 2024-.
The Office of Pharmaceutical Industry ResearchSenior Researcher Daisuke Kanai
The Office of Pharmaceutical Industry ResearchSenior Researcher Kumi Yoshino -
Survey of Originator Companies in the U.S. Development Pipeline
The Office of Pharmaceutical Industry Research Senior Researcher Chie Chie Yoshiura
The Office of Pharmaceutical Industry ResearchSenior Researcher Kiyoshi Morimoto
The Office of Pharmaceutical Industry ResearchSenior Researcher Daisuke Kanai -
Importance of Geographic Concentration in Drug Discovery
-Comparison of Drug Discovery Originators and Drug Discovery Support Environments across Metropolitan Areas
The Office of Pharmaceutical Industry Research Senior Researcher Kiyoshi Morimoto
The Office of Pharmaceutical Industry ResearchSenior Researcher Chie Yoshiura
The Office of Pharmaceutical Industry ResearchSenior Researcher Daisuke Kanai -
A Survey of the Characteristics of New Drugs Approved Prior to Japan and Related Factors
-A Study on the Characteristics of New Drugs Approved in Japan and Related Factors - From the Perspective of NHI Calculation and Overseas Situation
The Office of Pharmaceutical Industry Research Senior Researcher Kumi Yoshino
The Office of Pharmaceutical Industry ResearchSenior Researcher Takahiro Shiraishi -
The Utilization of Wearable Devices in Drug Development
-Trend Analysis of Wearable Devices in Drug Development - Trend Analysis to June 2025
The Office of Pharmaceutical Industry Research Senior Researcher Mariko Togashi
The Office of Pharmaceutical Industry ResearchSenior Researcher Natsuko Watanabe
The Office of Pharmaceutical Industry ResearchSenior Researcher Makoto Edahiro
